Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page
- Check4 days agoChange DetectedThe page now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects an update to the page's version tag rather than changes to study content or functionality.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now displays 'No longer looking for participants', indicating that enrollment is closed for this study. Other updates include adding navigation/help sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study', and updating the revision label to v3.6.0, along with minor formatting tweaks to headers.SummaryDifference0.5%

- Check25 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor site release. There are no changes to the study details or user-facing content evident in this update.SummaryDifference0.1%

- Check47 days agoChange DetectedA platform revision was updated from v3.5.3 to v3.5.4, indicating an underlying update to the site. It does not modify the study information or how the page is used.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page’s footer revision/version indicator changes from **Revision: v3.5.0** to **Revision: v3.5.3**, reflecting an update to the ClinicalTrials.gov site build rather than any study content.SummaryDifference0.1%

- Check105 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.